Geode Capital Management
SANA icon

Geode Capital Management’s Sana Biotechnology SANA Stock Holding History

Geode Capital Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3M Buy
4,677,959
+495,986
+12% +$1.6M ﹤0.01% 2275
2026
Q1 		$12M Buy
4,181,973
+63,835
+2% +$251K ﹤0.01% 2277
2025
Q4 		$16.8M Buy
4,118,138
+694,606
+20% +$3.11M ﹤0.01% 2109
2025
Q3 		$12.2M Buy
3,423,532
+143,741
+4% +$520K ﹤0.01% 2304
2025
Q2 		$8.96M Buy
3,279,791
+4,523
+0.1% +$9.33K ﹤0.01% 2434
2025
Q1 		$5.5M Buy
3,275,268
+82,187
+3% +$230K ﹤0.01% 2611
2024
Q4 		$5.21M Buy
3,193,081
+26,601
+0.8% +$79.3K ﹤0.01% 2731
2024
Q3 		$13.2M Buy
3,166,480
+276,055
+10% +$1.45M ﹤0.01% 2212
2024
Q2 		$15.8M Buy
2,890,425
+473,907
+20% +$3.78M ﹤0.01% 2057
2024
Q1 		$24.2M Buy
2,416,518
+162,682
+7% +$1.22M ﹤0.01% 1805
2023
Q4 		$9.2M Buy
2,253,836
+206,248
+10% +$760K ﹤0.01% 2394
2023
Q3 		$7.93M Buy
2,047,588
+65,058
+3% +$350K ﹤0.01% 2401
2023
Q2 		$11.8M Buy
1,982,530
+201,565
+11% +$1.16M ﹤0.01% 2188
2023
Q1 		$5.82M Sell
1,780,965
-27,399
-2% -$109K ﹤0.01% 2569
2022
Q4 		$7.14M Buy
1,808,364
+109,863
+6% +$537K ﹤0.01% 2470
2022
Q3 		$10.2M Buy
1,698,501
+47,279
+3% +$341K ﹤0.01% 2241
2022
Q2 		$10.6M Buy
1,651,222
+124,511
+8% +$793K ﹤0.01% 2207
2022
Q1 		$12.6M Sell
1,526,711
-22,472
-1% -$182K ﹤0.01% 2192
2021
Q4 		$24M Buy
1,549,183
+7,551
+0.5% +$146K ﹤0.01% 1831
2021
Q3 		$34.7M Buy
1,541,632
+991,384
+180% +$20.8M ﹤0.01% 1584
2021
Q2 		$10.8M Buy
550,248
+137,811
+33% +$3.12M ﹤0.01% 2403
2021
Q1 		$13.8M Buy
+412,437
New +$13.4M ﹤0.01% 2121

Other funds holding SANA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Geode Capital Management's SANA Position: Q2 2026 in Review

Geode Capital Management increased its Sana Biotechnology (SANA) stake by 12% in Q2 2026, buying an estimated $1.6M and bringing the position to 4,677,959 shares worth $16.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2275.

Geode Capital Management first reported a position in SANA in Q1 2021 and has held it in 22 quarters since. The position peaked at $34.7M in Q3 2021. 197 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Geode Capital Management held 4,677,959 shares of Sana Biotechnology worth $16.3M as of Q2 2026.
  • Geode Capital Management bought 495,986 Sana Biotechnology shares in Q2 2026, an estimated $1.6M.
  • Sana Biotechnology made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2275 holding.
  • Geode Capital Management first reported a position in Sana Biotechnology in Q1 2021 and has held it in 22 quarters since.
  • Geode Capital Management's Sana Biotechnology position peaked at $34.7M in Q3 2021.
  • 197 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.